📣 VC round data is live. Check it out!
- Public Comps
- OrthoPediatrics
OrthoPediatrics Valuation Multiples
Discover OrthoPediatrics' revenue and EBITDA valuation multiples and M&A history, alongside public comparables like Imricor Medical Systems, Kamada, Medistim, Revenio Group and more.
OrthoPediatrics Overview
About OrthoPediatrics
OrthoPediatrics Corp is a medical device company. The company is engaged in providing products to the pediatric orthopedic market. The firm designs develop and commercialize implants and instruments to meet the needs of surgeons and patients. Its products, include PediLoc, PediPlates, Cannulated Screws, PediFlexTM nail, PediNailTM, PediLoc Tibia and ACL Reconstruction System among others.
Founded
2007
HQ

Employees
562
Website
Financials (LTM)
EV
$484M
Valuation Multiples
Start free trialOrthoPediatrics Financials
OrthoPediatrics reported last 12-month revenue of $249M and EBITDA of $19M.
In the same LTM period, OrthoPediatrics generated $182M in gross profit, $19M in EBITDA, and had net loss of ($34M).
Revenue (LTM)
OrthoPediatrics P&L
In the most recent fiscal year, OrthoPediatrics reported revenue of $236M and EBITDA of $15M.
OrthoPediatrics is unprofitable as of last fiscal year, with gross margin of 73%, EBITDA margin of 6%, and net margin of (17%).
Financial data powered by Morningstar, Inc.
OrthoPediatrics Stock Performance
OrthoPediatrics has current market cap of $432M, and enterprise value of $484M.
Market Cap Evolution
OrthoPediatrics' stock price is $16.81.
OrthoPediatrics share price decreased by 2.1% in the last 30 days, and by 21.7% in the last year.
OrthoPediatrics has an EPS (earnings per share) of $-1.54.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $484M | $432M | 0.8% | -2.1% | 5.9% | -21.7% | $-1.54 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialOrthoPediatrics Valuation Multiples
OrthoPediatrics trades at 1.9x EV/Revenue multiple, and 25.2x EV/EBITDA.
EV / Revenue (LTM)
OrthoPediatrics Financial Valuation Multiples
As of June 3, 2026, OrthoPediatrics has market cap of $432M and EV of $484M.
OrthoPediatrics has a P/E ratio of (12.6x).
Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified OrthoPediatrics Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.


OrthoPediatrics Margins & Growth Rates
OrthoPediatrics grew revenue by 12% and EBITDA by 71% in the last fiscal year.
In the most recent fiscal year, OrthoPediatrics reported gross margin of 73%, EBITDA margin of 6%, and net margin of (17%).
OrthoPediatrics Margins
OrthoPediatrics Growth Rates
Data powered by FactSet, Inc. and Morningstar, Inc.
OrthoPediatrics Operational KPIs
OrthoPediatrics' revenue per employee in the last FY averaged $0.4M, while opex per employee averaged $0.4M for the same period.
OrthoPediatrics' Rule of 40 is 22% (metric relevant for SaaS companies only, counted as combined revenue growth rate and EBITDA margin).
OrthoPediatrics' Rule of X is 40% (created by Bessemer, Rule of X is another metric to measure SaaS companies, ~1.5x stronger vs. the traditional Rule of 40, counted as revenue growth rate multiplied by 2.5 plus EBITDA margin).
Data powered by FactSet, Inc. and Morningstar, Inc.
OrthoPediatrics Competitors
OrthoPediatrics competitors include Imricor Medical Systems, Kamada, Medistim, Revenio Group, Vicenne, Standard BioTools, Perspective Therapeutics, AngioDynamics, Tess Holdings Co and Medios.
Most OrthoPediatrics public comparables operate across Medical Devices, DeepTech and HealthTech.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| Last FY | LTM | 2027E | Last FY | LTM | 2027E | |
| 1456.5x | 264.3x | (19.8x) | (18.9x) | |||
| 2.1x | 2.0x | 9.1x | 8.3x | |||
| 5.6x | 5.5x | 16.6x | 18.2x | |||
| 3.3x | 2.9x | 11.6x | 11.3x | |||
| 2.9x | - | 12.6x | - | |||
| 0.3x | 0.3x | (0.4x) | (0.6x) | |||
| 162.7x | 213.0x | (1.4x) | (1.2x) | |||
| 1.4x | 1.3x | 54.4x | 33.3x | |||
This data is available for Pro users. Sign up to see all OrthoPediatrics competitors and their valuation data. Start Free Trial | ||||||
Acquisitions by OrthoPediatrics
OrthoPediatrics has acquired 4 companies to date.
Last acquisition by OrthoPediatrics was on January 8th 2024. OrthoPediatrics acquired Boston Orthotics & Prosthetics for $22M (EV/Revenue multiple available to Pro users).
Latest Acquisitions by OrthoPediatrics
| Description | Boston Orthotics & Prosthetics is a Boston-based provider of pediatric orthotic and prosthetic devices affiliated with Children's Hospital. Established in 1902, it fabricates custom braces for scoliosis, clubfoot, and cerebral palsy using CAD-CAM design. The clinic treats 2,000 patients yearly with carbon fiber limbs and dynamic ankle-foot orthoses. Boston Orthotics & Prosthetics holds ABC certification and collaborates on prosthetics research at Harvard Medical School. | Pega Medical is a medical device company focused on trauma and deformity solutions for pediatric patients. It develops the Fassier-Duval Telescopic Intramedullary System, an implant that corrects bony deformities in children with osteogenesis imperfecta while allowing natural bone growth. | MD Orthopaedics is a North America-leading producer of nonsurgical clubfoot treatment devices and ankle-foot orthoses, distributing over 20 products including Ponseti-method boots, abduction bars, training kits, and accessories to 126 countries. The Iowa-based company employs 28 staff at its Cedar Falls facility, serving hundreds of thousands of patients through orthopedic clinics, hospitals, and Ponseti centers. As a member of the American Orthotic and Prosthetic Association, MD Orthopaedics maintains FDA clearance for its AFOs and provides clinician training materials endorsed by the International Federation of Ponseti Method. | ApiFix is a minimally invasive system for correcting adolescent idiopathic scoliosis in patients classified as Lenke Type 1 or Type 5 with Cobb angles between 35 and 55 degrees. The approach involves a single small incision followed by gradual correction over months through specialized physical therapy, avoiding the risks of extensive open surgery. Petah Tikva-based in Israel, ApiFix provides orthopedic surgeons with an outpatient alternative that preserves spinal growth potential while achieving deformity reduction. |
| HQ Country | ||||
| HQ City | Hartford, CT | Laval | Boston, MA | Misgav Dov |
| Deal Date | 8 Jan 2024 | 14 Jun 2022 | 4 Apr 2022 | 2 Apr 2020 |
| Valuation | $22M | $33M | $20M | $67M |
| EV/Revenue | ||||
| EV/EBITDA | ||||
This data is available for Pro users. Sign up to see all OrthoPediatrics acquisitions and their M&A valuation multiples. Start Free Trial | ||||
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout OrthoPediatrics
| When was OrthoPediatrics founded? | OrthoPediatrics was founded in 2007. |
| Where is OrthoPediatrics headquartered? | OrthoPediatrics is headquartered in United States. |
| How many employees does OrthoPediatrics have? | As of today, OrthoPediatrics has over 562 employees. |
| Who is the CEO of OrthoPediatrics? | OrthoPediatrics' CEO is David R. Bailey. |
| Is OrthoPediatrics publicly listed? | Yes, OrthoPediatrics is a public company listed on Nasdaq. |
| What is the stock symbol of OrthoPediatrics? | OrthoPediatrics trades under KIDS ticker. |
| When did OrthoPediatrics go public? | OrthoPediatrics went public in 2017. |
| Who are competitors of OrthoPediatrics? | OrthoPediatrics main competitors include Imricor Medical Systems, Kamada, Medistim, Revenio Group, Vicenne, Standard BioTools, Perspective Therapeutics, AngioDynamics, Tess Holdings Co, Medios. |
| What is the current market cap of OrthoPediatrics? | OrthoPediatrics' current market cap is $432M. |
| What is the current revenue of OrthoPediatrics? | OrthoPediatrics' last 12 months revenue is $249M. |
| What is the current revenue growth of OrthoPediatrics? | OrthoPediatrics revenue growth (NTM/LTM) is 12%. |
| What is the current EV/Revenue multiple of OrthoPediatrics? | Current revenue multiple of OrthoPediatrics is 1.9x. |
| What is the current EBITDA of OrthoPediatrics? | OrthoPediatrics' last 12 months EBITDA is $19M. |
| What is OrthoPediatrics' EBITDA margin? | OrthoPediatrics' last 12 months EBITDA margin is 8%. |
| What is the current EV/EBITDA multiple of OrthoPediatrics? | Current EBITDA multiple of OrthoPediatrics is 25.2x. |
| How many companies OrthoPediatrics has acquired to date? | As of June 2026, OrthoPediatrics has acquired 4 companies. |
| What was the largest acquisition by OrthoPediatrics? | $67M acquisition of ApiFix on 2nd April 2020 was the largest M&A OrthoPediatrics has done to date. |
| What companies OrthoPediatrics acquired? | OrthoPediatrics acquired ApiFix, Pega Medical, Boston Orthotics & Prosthetics, and MD Orthopaedics. |
| In how many companies OrthoPediatrics has invested to date? | OrthoPediatrics hasn't invested in any companies yet (or none have been disclosed publicly). |
See public comps similar to OrthoPediatrics
Lists including OrthoPediatrics
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.


